L&K Biomed's New Cervical Products Receive Positive Feedback at AANS in U.S., Raising Expectations for North American Market Expansion

L&K Spine participating in the 'AANS Conference' and explaining products to attendees. Provided by L&K Biomed

L&K Biomed showcased its new cervical products at the American Association of Neurological Surgeons (AANS) conference, reaffirming its potential for global market expansion.

According to the company on May 6, its U.S. subsidiary, L&K Spine, participated in the AANS conference held in Texas, United States, from May 1 to May 3. At the event, the company introduced its spinal implant product lineup and engaged with global medical professionals.

The AANS, which began as a gathering primarily for U.S. medical professionals, has evolved into an international academic conference. It now brings together neurosurgery specialists and medical device industry representatives from around the world to share the latest clinical research, surgical techniques, and medical technology trends, and is regarded as a prestigious event in the field.

At this event, L&K Spine operated an independent booth, exhibiting its main product line—including expandable cages—while conducting demonstrations and collecting feedback. This allowed the company to directly validate its technological capabilities and clinical applicability on site and provided an effective opportunity to promote its competitiveness to global medical professionals.

In particular, there was a positive response to the company's cervical products currently undergoing U.S. Food and Drug Administration (FDA) approval, such as 'BluEX-C' and 'Castleloc P 2.0'. Despite being in the pre-launch stage, these products attracted significant interest from local medical professionals. The expandable cervical cage 'BluEX-C', in particular, generated a strong intention to use among practitioners, thanks to its differentiated technology even in a limited supply environment.

The conference also attracted attention from major domestic distributors in the United States, laying the groundwork for building and strengthening future supply chain operations. In addition, the company secured a foundation for further product improvement by incorporating diverse on-site feedback and confirmed the potential for future distribution network expansion.

Through its participation, L&K Biomed once again demonstrated its global expansion potential by drawing interest from medical professionals not only in North America but also in Mexico, Brazil, and other Latin American regions. The company also expanded its network with local medical professionals, established a base for discovering new partnerships, and plans to strengthen its supply chain and operational capabilities by expanding cooperation with U.S. hospitals.

The company is also working to expand its supply network nationwide across the United States by cooperating with major global firms. Going forward, its strategy is to further enhance its competitiveness in the spinal implant market through continuous technological innovation and clinically driven product development.

An official from L&K Biomed stated, "The U.S. medical device market is a core market that demands high regulatory standards and clinical reliability, so expanding our presence directly proves our technological capabilities. We are building a stronger market foundation by accumulating clinical credibility through cooperation with local medical professionals." The official added, "Based on the insights gained from this conference, we will advance our products and implement locally tailored strategies step by step to achieve tangible results."

The participation in this conference was significant for L&K Biomed, as it demonstrated the technological competitiveness of its new cervical products and secured a foundation for expanding into the North American and Latin American markets.

This content was produced with the assistance of AI translation services.